U.S. FDA panel to review Oralair for approval: documents
(Reuters) - An oral immunotherapy aimed at grass and pollen allergies has a benefit and safety profile that supports its approval, according to compan...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/fZDFGA597fc/story01.htm
No comments:
Post a Comment